Life Sciences

Marlborough medical device manufacturer Boston Scientific Corp. has acquired Obsidio, Inc., a South Carolina-based medical materials developer.

ReWalk Robotics is working with CMS to classify one of its products as artificial legs, which would make it easier for patients to receive its products.

Marlborough medical device manufacturer Boston Scientific Corp. has received a whistleblower letter saying the company violated the U.S. Foreign Corrupt Practices Act in its dealings in Vietnam.

Holliston bioscience company Biostage has hired a public financing and Nasdaq listing expert as its new CFO. 

Rentschler Biopharma, a German contract development and manufacturing company with a growing presence in Milford, has added two newly created senior-level positions to its leadership team.

Greater Worcester is ranked among the top 25 life science research talent pools, according to a report from Dallas real estate services and investment firm CBRE Group, Inc. 

Marlborough medical-device giant Boston Scientific Corp. will exercise its option to purchase remaining shares of California manufacturer Farapulse Inc. in a deal that, when settled, could total $575 million, the company announced in June.

Marlborough-based Boston Scientific Corp. will pay California medical device manufacturer Nevro Corp. $85 million to settle all intellectual property litigation between the two companies.

Marlborough medical device manufacturer Hologic, Inc. saw its revenue drop by 14.2% in the third quarter, but the company’s performance was significantly better than Hologic itself predicted just a few months ago. 

Milford lab equipment manufacturer Waters Corp. is working with University of Minnesota researchers to advance the science of plant-based proteins.